"Ionomycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A divalent calcium ionophore that is widely used as a tool to investigate the role of intracellular calcium in cellular processes.
| Descriptor ID |
D015759
|
| MeSH Number(s) |
D10.251.355.391
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ionomycin".
Below are MeSH descriptors whose meaning is more specific than "Ionomycin".
This graph shows the total number of publications written about "Ionomycin" by people in this website by year, and whether "Ionomycin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ionomycin" by people in Profiles.
-
Beal AM, Anikeeva N, Varma R, Cameron TO, Vasiliver-Shamis G, Norris PJ, Dustin ML, Sykulev Y. Kinetics of early T cell receptor signaling regulate the pathway of lytic granule delivery to the secretory domain. Immunity. 2009 Oct 16; 31(4):632-42.
-
Leucci E, De Falco G, Onnis A, Cerino G, Cocco M, Luzzi A, Crupi D, Tigli C, Bellan C, Tosi P, Leoncini L, Giordano A. The role of the Cdk9/Cyclin T1 complex in T cell differentiation. J Cell Physiol. 2007 Aug; 212(2):411-5.
-
Brando C, Mukhopadhyay S, Kovacs E, Medina R, Patel P, Catina TL, Campbell KS, Santoli D. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104. J Leukoc Biol. 2005 Aug; 78(2):359-71.
-
Genetos DC, Geist DJ, Liu D, Donahue HJ, Duncan RL. Fluid shear-induced ATP secretion mediates prostaglandin release in MC3T3-E1 osteoblasts. J Bone Miner Res. 2005 Jan; 20(1):41-9.
-
Zhang T, He X, Tsang TC, Harris DT. SING: a novel strategy for identifying tumor-specific, CTL-recognized tumor antigens. FASEB J. 2004 Mar; 18(3):600-2.